Protagonist Therapeutics, Inc（PTGX）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Protagonist Therapeutics, Inc（PTGX）报告了 104 笔 Form 4 交易（最近一笔 2026-10-02）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Ali Asif | Chief Financial Officer | 买入 | 9,229 | $359,746 |
| 2026-10-02 | Ali Asif | Chief Financial Officer | 买入 | 28,438 | $666,018 |
| 2026-10-02 | Ali Asif | Chief Financial Officer | 买入 | 15,650 | $300,324 |
| 2026-10-02 | Ali Asif | Chief Financial Officer | 买入 | 5,312 | $64,647 |
| 2026-10-02 | Ali Asif | Chief Financial Officer | 卖出 | 12,595 | $1.8M |
| 2026-10-02 | Ali Asif | Chief Financial Officer | 卖出 | 46,034 | $6.5M |
| 2026-09-10 | PATEL DINESH V PH D | President and CEO | 买入 | 54,174 | $1.2M |
| 2026-09-10 | PATEL DINESH V PH D | President and CEO | 卖出 | 54,174 | $7.9M |
| 2026-09-10 | PATEL DINESH V PH D | President and CEO | 买入 | 63,548 | $1.4M |
| 2026-09-10 | PATEL DINESH V PH D | President and CEO | 卖出 | 63,548 | $9.3M |
| 2026-09-10 | PATEL DINESH V PH D | President and CEO | 买入 | 7,278 | $157,059 |
| 2026-09-10 | PATEL DINESH V PH D | President and CEO | 卖出 | 7,278 | $1.0M |
| 2026-09-08 | PATEL DINESH V PH D | President and CEO | 卖出 | 510 | $0 |
| 2026-08-12 | PATEL DINESH V PH D | President and CEO | 买入 | 65,761 | $1.4M |
| 2026-08-12 | PATEL DINESH V PH D | President and CEO | 卖出 | 65,761 | $9.8M |
| 2026-08-12 | PATEL DINESH V PH D | President and CEO | 买入 | 34,239 | $738,878 |
| 2026-08-12 | PATEL DINESH V PH D | President and CEO | 卖出 | 34,239 | $5.1M |
| 2026-06-25 | Waddill William D. | 董事 | 买入 | 9,000 | $148,860 |
| 2026-06-25 | Waddill William D. | 董事 | 卖出 | 9,000 | $1.1M |
| 2026-06-11 | Waddill William D. | 董事 | 买入 | 3,000 | $35,400 |
| 2026-06-11 | Waddill William D. | 董事 | 买入 | 6,000 | $99,240 |
| 2026-06-11 | Waddill William D. | 董事 | 卖出 | 9,000 | $969,120 |
| 2026-06-01 | Waddill William D. | 董事 | 买入 | 9,000 | $106,200 |
| 2026-06-01 | Waddill William D. | 董事 | 卖出 | 9,000 | $896,760 |
| 2026-05-14 | PATEL DINESH V PH D | President and CEO | 买入 | 75,000 | $1.6M |
来源：SEC Form 4 申报文件 · 截至 2026-10-02